Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15... Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. Mehr anzeigen
MIAMI, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs today launched NVOX, the world's first single-stock leveraged ETF for the pharmaceutical stock Novo Nordisk (NYSE: NVO). As the weight loss...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -8.32 | -9.53909653749 | 87.22 | 87.28 | 78.69 | 8639304 | 83.20451242 | CS |
| 4 | -3.8 | -4.59492140266 | 82.7 | 89.1 | 78.69 | 10614553 | 85.30436479 | CS |
| 12 | -35 | -30.7287093942 | 113.9 | 114.19 | 78.69 | 7267807 | 97.7823962 | CS |
| 26 | -57.51 | -42.1596657137 | 136.41 | 139.735 | 78.69 | 5432289 | 109.56164226 | CS |
| 52 | -27.34 | -25.734186747 | 106.24 | 148.15 | 78.69 | 4920543 | 117.83603838 | CS |
| 156 | 31.065 | 64.941988084 | 47.835 | 148.15 | 45.755 | 2964602 | 100.17773468 | CS |
| 260 | 48.17 | 156.752359258 | 30.73 | 148.15 | 24.62 | 2265933 | 86.42690029 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
